Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Contender In Race To Plant ‘Natural’ Flag Wields Consumer View

This article was originally published in The Tan Sheet

Executive Summary

While industry trade associations and research groups develop or already offer certifications so firms can tell consumers their products are approved as natural by expert evaluators, Organic & Natural Health Association approaches the challenge from the viewpoint of consumers wanting to know.

You may also be interested in...



Regulating 'Natural' In Supplement Labeling Would Stem Rise In Litigation – CRN

CRN urges FDA to mirror the USDA National Organic Program's tiered approach to organic claims in a regulation on the use of “natural” in supplement and food labels. The agency should allow natural labeling beyond raw ingredients and single-ingredient products, says CRN.

FTC Diagnosis For 'Doctor Trusted' Certificates: 'Meaningless'

"Doctor Trusted" certificates were based on two doctors "superficially" reviewing products online without actually evaluating the products or determining whether advertising claims were supported.

FDA Compelled To Test ‘Natural’ Climate But Hedges On Rulemaking Forecast

FDA notes three citizen petitions asking the agency to define “natural” for use in food labeling and one asking it to prohibit the term on labels in addition to federal courts requesting administrative determinations,. But a rulemaking might not be the outcome, and any decision will be a long time in coming.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS107965

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel